Isoquercitrin ameliorates chondrocyte dysfunction in osteoarthritis by targeting AKT1-mediated mitochondrial dynamics regulation
Yuan Ding, Xiang Wang, Shihua Zong, Qiong Wen, Luyang Zhang · 2026
Read Isoquercitrin ameliorates chondrocyte dysfunction in osteoarthritis by targeting AKT1-mediated mitochondrial dynamics regulation by Yuan Ding, Xiang Wang, Shihua Zong, Qiong Wen, Luyang Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0357989.txt.
Description
Yuan Ding led a team of five authors studying a plant compound and joint cartilage, published in PLOS ONE in 2026. The compound, isoquercitrin, comes from plants and belongs to a group known for protective effects in cells. The team studied worn cartilage cells, the kind that fail in osteoarthritis.
Ding's group found that the compound eased cell dysfunction by acting on a protein called AKT1 and on how the cells manage their mitochondria, their energy centers. Healthier cartilage cells in the lab mark the compound as a candidate worth further testing. Osteoarthritis has few drugs that slow it, so even early cell-level leads draw interest from researchers hunting for gentler options.
Catalog record
| CREATOR | Yuan Ding, Xiang Wang, Shihua Zong, Qiong Wen, Luyang Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56779 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |